4,107 Views
•
08:27 min
•
September 02, 2021
DOI:
Podsumowanie
Automatically generated
This protocol describes two sensitive assays for discriminating among mild, moderate, and severe motor impairment in C. elegans models of amyotrophic lateral sclerosis, with general utility for C. elegans strains, with altered motility.
Powiązane Filmy
13:59
Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
Powiązane Filmy
25873 Views
09:07
Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles
Powiązane Filmy
21239 Views
12:35
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
Powiązane Filmy
28109 Views
07:46
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
Powiązane Filmy
11941 Views
10:33
A Caenorhabditis elegans Model System for Amylopathy Study
Powiązane Filmy
10546 Views
05:51
Comparative Analysis of Experimental Methods to Quantify Animal Activity in Caenorhabditis elegans Models of Mitochondrial Disease
Powiązane Filmy
2751 Views
06:49
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Powiązane Filmy
19691 Views
06:35
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Powiązane Filmy
19383 Views
10:13
Methods to Assess Subcellular Compartments of Muscle in C. elegans
Powiązane Filmy
16638 Views
10:49
Measuring RAN Peptide Toxicity in C. elegans
Powiązane Filmy
6663 Views
Read Article
Cytuj ten artykuł
Currey, H. N., Liachko, N. F. Evaluation of Motor Impairment in C. elegans Models of Amyotrophic Lateral Sclerosis. J. Vis. Exp. (175), e62699, doi:10.3791/62699 (2021).
Copy